Quoin Pharmaceuticals Ltd.
QNRX · Pharmaceutical Preparations
Latest available SEC filing: 4/A ·
Latest disclosures
-
Langer Dennis: Form 4/A
Insider disclosure · Filed · Report period 27 Aug 2026
-
Form 4/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- QNRX · 74907L409 - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
- QNRX · 74907L300 - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S
- QNRX · 74907L102 - SPON ADS NEW 21
- QNRX · 74907L201 - SPONSORED ADS
Company details and SEC sources
CIK 0001671502 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- QNRX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 42127 Pleasant Forest Court, Ashburn, VA, 20148-7349
- Incorporated in
- Israel
- Former names on EDGAR
- Cellect Biotechnology Ltd. (to 15 Oct 2021), Cellect Biomed Ltd. (to 07 Jul 2016)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields